Acción LEVBIO ALPHAHELIX MOLECULAR DIAGNOSTICS AB
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas AlphaHelix Molecular Diagnostics AB

Acciones

LEVBIO

SE0000885501

Precio de cierre NORDIC GROWTH MARKET
Otros sitios de cotización
 00:00:00 14/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,39 SEK -11,36 % Gráfico intradía de AlphaHelix Molecular Diagnostics AB -13,33 % -4,41 %
25/04 AlphaHelix Molecular Diagnostics AB (publ) informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
22/02 AlphaHelix Molecular Diagnostics AB (publ) informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter Ended September 30, 2023
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021
Alphahelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
Xanadu Technologies AB, Tataa Biocenter AB and Active Healthtech Nordic AB acquired a 13.17% stake in AlphaHelix Molecular Diagnostics AB from Labkompaniet AB.
AlphaHelix Molecular Diagnostics AB Appoints Peter Herte as Chief Executive Officer, Effective May 23, 2017
AlphaHelix Molecular Diagnostics AB Auditor Raises 'Going Concern' Doubt
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción LEVBIO
  4. Noticias AlphaHelix Molecular Diagnostics AB
  5. Otros idiomas